Pharma Gift, Marketing and Advertising Reporting Rules Multiply
States pile on rules; industry wishes for consistency
Cegedim Dendrite (Bedminster, NJ) is one of several firms now offering a service that tracks the proliferation of state-level rules on reporting gifts, sponsorships or other marketing activities that occur between manufacturers and healthcare providers. A chart from Cegedim Dendrite’s reporting service shows the growing complexity of this activity (see also Pharmaceutical Commerce, Jan/Feb).
The Pharmaceutical Research and Manufacturers Assn (PhRMA; Washington, DC) sought to forestall state activities like these with its voluntary marketing guidelines, the “Code on Interactions with Health Care Professionals.” For signatories to that code, the use of non-educational items like pens and coffee cups is now prohibited. As of February, according to PhRMA, 40 companies (including some non-PhRMA members) have signed the code—but it is not obligatory among even PhRMA members. Around then, the Biotechnology Industry Assn. (BIO, Washington, DC) adopted a similar measure.
Obviously, the industry codes have not satisfied state legislators who are writing more rules. Some states require item-by-item reporting, and some only want cumulative spending; some include medical devices and some do not. The expense of managing the various programs and their reporting requirements is represents another burden on the industry that Cegedim Dendrite and others are trying to address.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
